About SARS-CoV-2 Neutralizing Antibodies
Infection by the SARS-CoV-2 or immunized by vaccine against SARS-CoV-2 will induce immune responses, such as the production of antibodies in the blood. These antibodies can specifically bind with virus receptor binding domain (RBD) to block the binding of RBD with ACE2 on human cells surface, thus prevent the virus or its genetic material into the human cell and virus infection. These antibodies are named neutralizing antibodies.
The SARS-CoV-2 neutralizing antibodies are protective antibody produced by the human body after inoculation with novel coronavirus vaccine or infection with novel coronavirus. The kit is used to monitor the presence of neutralizing antibodies in subjects vaccinated with the novel coronavirus vaccine or in people infected with the novel coronavirus, it can be used to evaluate the immune effect after vaccination or whether neutralizing antibodies are produced in human body after infection with novel coronavirus, it should not be used to diagnose acute SARS-CoV-2 infection.
Immunofluorescent Analyzer (IFP-3000), Immunofluorescent Analyzer (IFP-2000) produced by Sichuan Xincheng Biological Co., Ltd.
Immunofluorescent Analyzer (AFS-1000) produced by Guangzhou Labsim Biotech Co., Ltd.
1) Test card: It consists of reagent strip and plastic bag.
2) ID chip card
3) Sample diluent
4) Capillary tube
5) User manual